|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
1R01CA206476-01
|
$772,521
|
$772,521
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
|
4K23CA160664-04
|
$122,436
|
$122,436
|
GODOY, GUILHERME
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$4,721
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$6,836
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$4,755
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$19,998
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$5,369
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
3P50CA186784-03S1
|
$750,000
|
$45,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$130,125
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-03
|
$2,161,998
|
$129,720
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-03
|
$555,997
|
$555,997
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-02
|
$669,859
|
$669,859
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$5,026
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$5,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$1,496
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S4
|
$350,000
|
$14,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
4P30CA033572-33
|
$2,520,000
|
$100,800
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeted Chemoprevention of Breast Cancer: From the Bench to Clinical Testing
|
5R01CA158668-06
|
$335,466
|
$167,733
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Towards Development of an in vitro Assay to Personalize Colonic Chemoprevention
|
5R03CA195143-02
|
$87,000
|
$87,000
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-08
|
$3,166,796
|
$3,166,796
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Effects of Vitamin D on Mammographic Density and Breast Tissue
|
5R01CA178263-03
|
$678,786
|
$678,786
|
REXRODE, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-17
|
$2,386,271
|
$167,039
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways
|
5K07CA188126-02
|
$144,000
|
$144,000
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
3U54CA163060-05S1
|
$462,954
|
$27,777
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S1
|
$20,833
|
$1,042
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S2
|
$60,000
|
$3,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S3
|
$118,406
|
$5,920
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S4
|
$200,000
|
$10,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
4K12CA076917-19
|
$672,520
|
$67,252
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
4P30CA043703-26
|
$4,895,515
|
$244,776
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
TIMP3: A Molecular Target of Green Tea Polyphenols
|
5R21CA193080-02
|
$206,843
|
$206,843
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
|
4R01CA168586-04
|
$328,888
|
$328,888
|
LETTERIO, JOHN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
|
5U01CA181770-03
|
$554,959
|
$554,959
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
3P50CA150964-05S1
|
$1,100,000
|
$99,000
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Natural Agent in Prevention of Prostate Cancer
|
5R21CA190921-02
|
$206,843
|
$206,843
|
SHUKLA, SANJEEV
|
CASE WESTERN RESERVE UNIVERSITY
|
|
S1P Lyase in colon cancer
|
3R01CA129438-09S2
|
$39,300
|
$9,825
|
OSKOUIAN, BABAK
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
S1P Lyase in colon cancer
|
4R01CA129438-09
|
$314,090
|
$78,523
|
OSKOUIAN, BABAK
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
Novel Role of Honokiol in Preventing Cancer during Immune Suppression
|
5R21CA191735-02
|
$198,336
|
$198,336
|
PAL, SOUMITRO
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
|
4R01CA172896-04
|
$335,154
|
$335,154
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Rice Bran Microbial Metabolism for Colon Chemoprevention
|
1R01CA201112-01A1
|
$364,133
|
$364,133
|
RYAN, ELIZABETH
|
COLORADO STATE UNIVERSITY
|
|
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts Esophagus
|
5R03CA186218-02
|
$81,186
|
$81,186
|
ABRAMS, JULIAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Increasing breast cancer chemoprevention in the primary care setting
|
5R01CA177995-03
|
$653,928
|
$653,928
|
CREW, KATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$4,800
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$2,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$4,875
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S4
|
$150,866
|
$6,035
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S5
|
$199,541
|
$7,982
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S6
|
$500,000
|
$20,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-42
|
$3,792,720
|
$151,709
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genomics and Mechanisms of Esophageal Carcinogenesis
|
1R01CA208711-01
|
$366,000
|
$109,800
|
SEPULVEDA, ANTONIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Chemoprevention for this search: $97,929,247
|